Felix Faupel is the Chief Business Officer at Rezon Bio, responsible for driving the company’s global commercial strategy and client partnerships. With more than a decade of experience across the biopharmaceutical and CDMO sectors, Felix brings a unique combination of scientific understanding and business acumen to help clients navigate the complexities of biologics development and manufacturing. Felix joined the organization during its evolution from Polpharma Biologics to Rezon Bio, where he play a key role in shaping its CDMO strategy and market positioning. Prior to that, he held senior leadership roles in biopharmaceutical CDMOs, including Chief Commercial Officer at Bacthera. Throughout his career, he has built high-performing commercial teams, led major partnership agreements, and supported clients from early-stage development through commercial launch. Felix holds an MSc and a BSc in Chemistry and Business Studies from the University of Zurich and is passionate about building collaborative, transparent relationships that create long-term value for clients and their patients.